lovastatin has been researched along with Epithelial Ovarian Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Gou, WF; Niu, ZF; Xiao, LJ; Zhao, Y; Zheng, HC | 1 |
1 other study(ies) available for lovastatin and Epithelial Ovarian Cancer
Article | Year |
---|---|
The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Caspase 3; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inhibitor of Apoptosis Proteins; Lovastatin; Matrix Metalloproteinase 9; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Phosphorylation; Proto-Oncogene Proteins c-akt; rho GTP-Binding Proteins; rhoC GTP-Binding Protein; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; STAT3 Transcription Factor; Survivin; Tissue Array Analysis; Transfection; Vascular Endothelial Growth Factor A; Young Adult | 2013 |